alexa Abstract | Pancreatic Neuroendocrine Tumors: Does Chemotherapy Work?

JOP. Journal of the Pancreas
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

Pancreatic neuroendocrine tumors (pNETs) are rare well-differentiated neoplasms which can be functional or nonfunctional.They tend to have a worse prognosis than their counterpart carcinoid tumors. Current systemic treatment optionsfor advanced, unresectable disease include somatostatin analogs, everolimus and sunitinib. Low response rates and toxicityprofiles have, thus far, limited the widespread use of cytotoxic chemotherapy in this setting. In this update, we review threeabstracts from the 2014 ASCO Gastrointestinal Cancers Symposium that present outcomes of the use of combinationcapecitabine and temozolomide in patients with advanced pNET. We summarize their results and discuss the role of thisregimen in treatment algorithms for metastatic pNET.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Muhammad Wasif Saif Mohamedtaki Abdulaziz Tejani

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords